Abstract:Growth differentiation factor-15 (GDF-15) is an emerging biomarker in several conditions. This SLR, conducted following PRISMA guidelines, examined the association between GDF-15 concentration and range of adverse outcomes in patients with heart failure (HF). Publications were identified from Embase® and Medline® bibliographic databases between January 1, 2014, and August 23, 2022 (congress abstracts: January 1, 2020, to August 23, 2022). Sixty-three publications met the eligibility criteria (55 manuscripts and 8 abstracts; 45 observational studies and 18 post hoc analyses of randomized controlled trials [RCTs]). Of the 19 outcomes identified, the most frequently reported longitudinal outcomes were mortality (n = 32 studies; all-cause [n = 27] or cardiovascular-related [n = 6]), composite outcomes (n = 28; most commonly mortality ± hospitalization/rehospitalization [n = 19]), and hospitalization/re-hospitalization (n = 11). The most common cross-sectional outcome was renal function (n = 22). Among longitudinal studies assessing independent relationships with outcomes using multivariate analyses (MVA), a significant increase in risk associated with higher baseline GDF-15 concentration was found in 22/24 (92 %) studies assessing all-cause mortality, 4/5 (80 %) assessing cardiovascular-related mortality, 13/19 (68 %) assessing composite outcomes, and 4/8 (50 %) assessing hospitalization/rehospitalization. All (7/7; 100 %) of the cross-sectional studies assessing the relationship with renal function by MVA, and 3/4 (75 %) assessing exercise capacity, found poorer outcomes associated with higher baseline GDF-15 concentrations. This SLR suggests GDF-15 is an independent predictor of mortality and other adverse but nonfatal outcomes in patients with HF. A better understanding of the prognostic role of GDF-15 in HF could improve clinical risk prediction models and potentially help optimize treatment regimens.

GDF15, an Emerging Player in Renal Physiology and Pathophysiology

Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15

Growth differentiation factor 15 (GDF-15) in kidney diseases

Krüppel-like Factor 15: A Potential Therapeutic Target for Kidney Disease

Role and Mechanism of Growth Differentiation Factor 15 in Chronic Kidney Disease

Role of GDF-15 in diabetic nephropathy: mechanisms, diagnosis, and therapeutic potential

Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?

Elevated serum GDF15 level as an early indicator of proximal tubular cell injury in acute kidney injury

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

Growth differentiation factor 15: Emerging role in liver diseases

Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients

Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: A systematic review and dose-response meta-analysis

Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort

GDF15 as a key disease target and biomarker: linking chronic lung diseases and ageing

Growth Differentiation Factor 15 Ameliorates Anti-Glomerular Basement Membrane Glomerulonephritis in Mice

Activation of the hypothalamic–pituitary–adrenal axis by exogenous and endogenous GDF15

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders

The research advances of GDF15 in the pulmonary diseases

Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review

Macrophages as a Source and Target of GDF-15

Growth Differentiation Factor 15 in Cardiovascular Diseases: from Bench to Bedside